CLS Holdings USA, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Note 14 - Commitment and Contingencies (Details)

Note 14 - Commitment and Contingencies (Details)										3 Months Ended		9 Months Ended		12 Months Ended
Note 14 - Commitment and Contingencies (Details)	Jan. 05, 2018 USD ($)	Nov. 30, 2017 USD ($) shares	Oct. 09, 2017 USD ($)	Aug. 23, 2017 USD ($)	Mar. 01, 2017 USD ($)	Jul. 20, 2016 USD ($)	Aug. 01, 2015 USD ($)	Apr. 17, 2015 ft²	Oct. 01, 2014 USD ($)	Feb. 28, 2018 USD ($)	Feb. 28, 2017 USD ($)	Feb. 28, 2018 USD ($)	Feb. 28, 2017 USD ($)	May 31, 2016 USD ($) shares	May 31, 2017 USD ($)
Note 14 - Commitment and Contingencies (Details) [Line Items]
Loss Contingency Accrual, Provision												$ 10,000
Debt Conversion, Original Debt, Amount											$ 100,000	112,500	$ 250,000
Employee-related Liabilities, Current										$ 40,562		40,562			$ 34,987
Allocated Share-based Compensation Expense												55,000	$ 0
Chief Executive Officer [Member]
Note 14 - Commitment and Contingencies (Details) [Line Items]
Employment Agreement, Term									5 years
Officers' Compensation									$ 150,000					$ 150,000
Deferred Compensation Arrangement with Individual, Description									performance bonus equal to 2% of CLS Labs’ annual EBITDA, up to a maximum annual cash compensation of $1 million (including his base salary)
Share-based Compensation Arrangement by Share-based Payment Award, Description									annual stock options, exercisable at the fair market value of CLS Labs’ common stock on the date of grant, in an amount equal to 2% of its annual EBITDA up to $42.5 million and 4% of its annual EBITDA in excess of $42.5 million
Employee-related Liabilities, Current										37,500		37,500			37,500
Chief Executive Officer [Member] \| Convertible Debt [Member] \| Unpaid Accrued Salary Converted to Convertible Note [Member]
Note 14 - Commitment and Contingencies (Details) [Line Items]
Debt Conversion, Original Debt, Amount	$ 37,500		$ 39,521	$ 62,500	$ 112,500	$ 250,000				37,500		112,500
Chief Operating Officer [Member]
Note 14 - Commitment and Contingencies (Details) [Line Items]
Employment Agreement, Term							5 years
Officers' Compensation							$ 150,000
Deferred Compensation Arrangement with Individual, Description							performance bonus equal to 2% of the Company’s annual EBITDA, up to a maximum annual cash compensation of $1 million (including his base salary)
Share-based Compensation Arrangement by Share-based Payment Award, Description							annual stock options, exercisable at the fair market value of the Company’s common stock on the date of grant, in an amount equal to 2% of its annual EBITDA up to $42.5 million and 4% of its annual EBITDA in excess of $42.5 million
Employee-related Liabilities, Current										37,500		37,500			0
Chief Operating Officer [Member] \| One Time Signing Bonus [Member]
Note 14 - Commitment and Contingencies (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in Shares) \| shares														250,000
Allocated Share-based Compensation Expense														$ 327,500
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period														1 year
President and Chief Financial Officer [Member]
Note 14 - Commitment and Contingencies (Details) [Line Items]
Officers' Compensation		$ 175,000
Deferred Compensation Arrangement with Individual, Description		performance bonus equal to 2% of the Company’s annual EBITDA, and annual restricted stock awards of the Company’s common stock in an amount equal to 3% of its annual EBITDA
Share-based Compensation Arrangement by Share-based Payment Award, Description		annual restricted stock awards of the Company’s common stock in an amount equal to 3% of its annual EBITDA
President and Chief Financial Officer [Member] \| One Time Signing Bonus [Member]
Note 14 - Commitment and Contingencies (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in Shares) \| shares		500,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period		1 year
Former Officer [Member]
Note 14 - Commitment and Contingencies (Details) [Line Items]
Employee-related Liabilities, Current										$ 16,250		16,250			$ 16,250
Building [Member]
Note 14 - Commitment and Contingencies (Details) [Line Items]
Area of Real Estate Property (in Square Feet) \| ft²								14,392
Lessee, Operating Lease, Term of Contract								72 months
Lessee, Operating Lease, Renewal Term								10 years
Deposits [Member]
Note 14 - Commitment and Contingencies (Details) [Line Items]
Loss Contingency Accrual, Provision												50,000
Rent Expense [Member]
Note 14 - Commitment and Contingencies (Details) [Line Items]
Loss Contingency Accrual, Provision												15,699
Remaining Amounts Due Under Lease [Member]
Note 14 - Commitment and Contingencies (Details) [Line Items]
Loss Contingency Accrual, Provision												$ 30,000